[Finished Printing? - Click Here to Return to Normal View]


NIDA Home > About NIDA > Organization > Child & Adolescent Workgroup (CAWG) > Prenatal Drug Exposure and Drug-Abusing Environments  

Child & Adolescent Workgroup (CAWG)
gray line



Prenatal Drug Exposure and Drug-Abusing Environments

Research Topics

Topics of interest in the area of the consequences of prenatal drug exposure include but are not limited to:

  • Physical and Neurobehavioral Outcomes in Fetal and Newborn Periods
  • Longitudinal Development (Infancy to Adolescence) in Multiple Domains
  • Analyses of Subtle Aspects of Developmental Functioning
  • Environmental Factors and Developmental Sequelae of Prenatal Drug Exposure including Animal Models
  • Methods of Prenatal Drug Exposure Assessment: Self-Report, Biological Markers, Dose and Timing, Measurement
  • Interventions to Prevent or Ameliorate Adverse Consequences
  • Basic Research including Various Animal Models
  • Gender differences in the All Aspects of Consequences of Drug Abuse

About NIDA Contents




NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, July 22, 2008. The U.S. government's official web portal